US FDA approves Sanofi’s bleeding disorder therapy
By Sriparna Roy and Padmanabhan Ananthan(Reuters) -The U.S. Food and Drug Administration approved French drugmaker Sanofi’s hemophilia therapy, introducing a new type of treatment administered every two months for patients with the rare blood clotting disorder,...
Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case
By Jonathan Stempel(Reuters) – A federal judge ordered a Johnson & Johnson unit on Friday to pay the U.S. government $1.64 billion after a jury found it liable in a whistleblower lawsuit for illegally promoting the HIV drugs Prezista and Intelence.U.S....
Musk to visit CIA on Monday, spokesperson says
WASHINGTON (Reuters) -Billionaire Elon Musk, who serves as a top adviser to President Donald Trump, will visit the Central Intelligence Agency on Monday to discuss government efficiency with director John Ratcliffe, a spokesperson said on Friday.The CIA has fired a...
OpenAI must complete for-profit transition by year-end to raise full $40 billion
By Krystal Hu and Jaspreet Singh(Reuters) – OpenAI must transition to a for-profit company by the end of the year to secure the full $40 billion funding led by SoftBank it is in the final stages of raising, a person familiar with the matter said on...
Top vaccine official Peter Marks forced out at FDA, WSJ reports
(Reuters) -The U.S. Food and Drug Administration’s top vaccine official, Peter Marks, has been pushed out, the Wall Street Journal reported on Friday.Marks, who played a key role in U.S. President Donald Trump’s first term in developing COVID-19 vaccines,...
No sign Trump will honor US auto tariff protections won by Canada, Mexico in 2018
By David Lawder and David Shepardson(Reuters) – Canada and Mexico won protections against potential new U.S. auto tariffs in 2018 as part of the U.S.-Mexico-Canada Agreement on trade, but there is no evidence that President Donald Trump will honor those...
IMF assessing Trump tariff plans but does not see US recession
WASHINGTON (Reuters) -The International Monetary Fund is continuing to assess the impact of President Donald Trump’s tariff plans, including his new 25% autos tariffs, but the IMF’s baseline forecasts do not envision a U.S. recession, IMF spokesperson...
H&M reports sluggish start to spring sales
By Helen ReidLONDON (Reuters) -H&M’s sales were up just 1% in March after a weaker than expected first quarter, the Swedish fast-fashion retailer reported on Thursday, in a sign of a slow start to its spring and summer season.H&M has ramped up marketing...